Xtl Biopharmaceuticals (XTLB) Total Non-Current Liabilities (2009 - 2025)
Xtl Biopharmaceuticals' Total Non-Current Liabilities came in at $352,000 for the quarter ended Dec 31, 2025, down 61.2% from $908,000 a year earlier.
Powered by 
Analysis
Xtl Biopharmaceuticals (XTLB) Total Non-Current Liabilities (2009 - 2025) Analysis & Trends
Going back to the quarter ended Dec 31, 2012, Xtl Biopharmaceuticals' Total Non-Current Liabilities data covers 21 quarters.
- Total Non-Current Liabilities carries a five-year compound annual growth rate of -33.2% (years ended Dec 2020 to Dec 2025).
- Going back by year, Total Non-Current Liabilities was $908,000 in the year ended Dec 31, 2024 and $1.29 million in the year ended Dec 31, 2021 (-51.3%).
- The figure for the quarter ended Dec 31, 2025 represents the lowest quarterly Total Non-Current Liabilities since the quarter ended Jun 30, 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 60.66 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 105.50 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 106.45 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 80.25 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 48.34 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 33.91 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 78.66 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 35.10 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 97.04 Bn |
| 10 | Xtl Biopharmaceuticals | 16.76 Mn | 13.56 Mn | - | 352,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 352,000.00 |
| Jun 30, 2025 | 724,000.00 |
| Dec 31, 2024 | 908,000.00 |
| Sep 30, 2024 | 765,000.00 |
| Jun 30, 2024 | 165,000.00 |
| Mar 31, 2024 | 223,000.00 |
| Dec 31, 2023 | 206,000.00 |
| Sep 30, 2023 | 162,000.00 |
| Jun 30, 2023 | 163,000.00 |
| Mar 31, 2023 | 241,000.00 |
| Dec 31, 2022 | 187,000.00 |
| Sep 30, 2022 | 153,000.00 |
| Jun 30, 2022 | 194,000.00 |
| Mar 31, 2022 | 517,000.00 |
| Dec 31, 2021 | 1.29 Mn |
| Sep 30, 2021 | 3.59 Mn |
| Jun 30, 2021 | 258,000.00 |
| Mar 31, 2021 | 2.69 Mn |
| Dec 31, 2020 | 2.64 Mn |
| Sep 30, 2020 | 1.36 Mn |
API Access
Xtl Biopharmaceuticals Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=XTLB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "XTLB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=XTLB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();